Revelation Biosciences In...

NASDAQ: REVB · Real-Time Price · USD
2.57
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:51 PM
2.60
1.33%
After-hours: Aug 15, 2025, 07:36 PM EDT

Revelation Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 26.96K n/a n/a n/a 37.57K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
7.22K 7.22K 13.48K 7.22K 7.22K 6.26K 18.79K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 21.22K 20.91K 20.42K 14.7K 9.97K
Gross Profit
-7.22K -7.22K 13.48K -7.22K -7.22K -6.26K 18.79K -6.26K -6.26K -6.26K -6.26K -6.26K -6.26K -21.22K -20.91K -20.42K -14.7K -9.97K
Operating Income
-2.46M -2.1M -1.75M -1.8M -2.52M -1.9M -2.33M -2.78M -1.93M -1.62M -1.22M -1.2M -1.86M -6.59M -3.86M -3.04M -2.44M -2.61M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 28.73K n/a n/a n/a n/a n/a n/a
Pretax Income
-5.63M -2.05M -1.73M -2.24M -8.39M -2.68M -2.2M -2.63M -1.45M 6.16M -1.21M -1.17M -1.83M -6.62M -3.86M -3.04M -2.47M -2.61M
Net Income
-2.44M -2.05M -1.73M -2.24M -8.39M -2.68M -2.2M -2.63M -1.45M 6.16M -1.21M -1.17M -1.83M -6.62M -3.86M -3.04M -2.47M -2.61M
Selling & General & Admin
1.14M 1.24M 1.15M 965.71K 1.13M 1.19M 1.27M 1.13M 1.02M 1.09M 878.36K 817.9K 884.84K 2.91M 1.19M 1.51M 1.28M 1.05M
Research & Development
1.32M 858.83K 605.5K 830.98K 1.4M 717.58K 1.06M 1.65M 909.28K 525.27K 339.97K 381.57K 975.58K 3.68M 2.67M 1.53M 1.16M 1.56M
Other Expenses
n/a 170.00 496.00 314.00 n/a -582 n/a n/a -278 -273 -327 n/a -420 n/a n/a n/a n/a n/a
Operating Expenses
2.46M 2.1M 1.75M 1.8M 2.52M 1.9M 2.33M 2.78M 1.93M 1.62M 1.22M 1.2M 1.86M 6.59M 3.86M 3.04M 2.44M 2.61M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 41.76K 557.00 n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.46M 2.1M 1.75M 1.8M 2.52M 1.9M 2.33M 2.78M 1.93M 1.62M 1.22M 1.2M 1.86M 6.59M 3.86M 3.04M 2.44M 2.61M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -32.91K n/a n/a n/a
Shares Outstanding (Basic)
802.67K 971.31K 346.5K 167.5K 102.2K 68.11K 16.53K 13.12K 12.11K 4.61K 1.42K 1.25K 897.78 845.35 587.59 374.51 374.51 374.42
Shares Outstanding (Diluted)
802.67K 971.31K 346.5K 167.5K 102.2K 68.11K 16.53K 13.12K 12.11K 6.53K 1.42K 1.25K 897.78 845.35 587.59 374.51 374.51 374.42
EPS (Basic)
-7.01 -2.11 -4.98 -13.38 -82.09 -39.37 -133.24 -200.34 -119.6 1.34K -848.74 -934.08 -2.04K -7.83K -6.57K -8.13K -6.59K -6.98K
EPS (Diluted)
-7.01 -2.11 -4.98 -13.38 -82.09 -39.37 -133.24 -200.34 -119.6 942.76 -848.74 -934.08 -2.04K -7.83K -6.57K -8.13K -6.59K -6.98K
EBITDA
-2.46M -2.09M -1.75M -1.79M -2.52M -1.9M -2.32M -2.77M -1.93M -1.61M -1.21M -1.19M -1.85M -6.58M -3.85M -3.04M -2.44M -2.61M
EBIT
-2.44M -2.1M -1.75M -1.8M -2.52M -1.9M -2.33M -2.78M -1.93M -1.62M -1.22M -1.2M -1.86M -6.59M -3.86M -3.04M -2.44M -2.61M
Depreciation & Amortization
7.22K 7.22K 7.22K 7.22K 7.22K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.26K 6.07K 3.81K 642.00